Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Onchocerca volvulus | Get druggable targets OG5_131470 | All targets in OG5_131470 | |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Trichomonas vaginalis | set domain proteins, putative | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Brugia malayi | Pre-SET motif family protein | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | casein kinase I, isoform 2 | 0.0355 | 1 | 1 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.676 | 0.676 |
Trypanosoma cruzi | casein kinase, putative | 0.0355 | 1 | 1 |
Trypanosoma cruzi | casein kinase, delta isoform, putative | 0.0347 | 0.9772 | 0.9605 |
Plasmodium vivax | casein kinase 1, putative | 0.0355 | 1 | 1 |
Onchocerca volvulus | 0.0171 | 0.4229 | 0.4229 | |
Trypanosoma cruzi | casein kinase, putative | 0.0355 | 1 | 1 |
Echinococcus multilocularis | casein kinase I alpha | 0.0355 | 1 | 1 |
Echinococcus granulosus | protein kinase shaggy | 0.0171 | 0.4229 | 0.4229 |
Echinococcus multilocularis | casein kinase I delta | 0.0355 | 1 | 1 |
Trypanosoma cruzi | casein kinase, delta isoform, putative | 0.0355 | 1 | 1 |
Loa Loa (eye worm) | CK1/CK1/CK1-D protein kinase | 0.0355 | 1 | 1 |
Toxoplasma gondii | cell-cycle-associated protein kinase GSK, putative | 0.0171 | 0.4229 | 0.4229 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.676 | 0.676 |
Brugia malayi | casein kinase I | 0.0355 | 1 | 1 |
Trypanosoma cruzi | casein kinase, putative | 0.0355 | 1 | 1 |
Echinococcus multilocularis | casein kinase I gamma | 0.0283 | 0.7752 | 0.7752 |
Entamoeba histolytica | casein kinase 1, putative | 0.0355 | 1 | 1 |
Echinococcus multilocularis | casein kinase I alpha | 0.0355 | 1 | 1 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 0.785 | 0.6274 |
Loa Loa (eye worm) | casein kinase | 0.0276 | 0.7524 | 0.7524 |
Giardia lamblia | Kinase, CK1 Casein kinase | 0.0355 | 1 | 1 |
Loa Loa (eye worm) | CK1/CK1/CK1-A protein kinase | 0.0355 | 1 | 1 |
Echinococcus multilocularis | casein kinase I delta | 0.0355 | 1 | 1 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0171 | 0.4229 | 0.4229 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0283 | 0.7752 | 0.7752 |
Echinococcus granulosus | casein kinase i | 0.0355 | 1 | 1 |
Onchocerca volvulus | 0.0355 | 1 | 1 | |
Plasmodium vivax | glycogen synthase kinase 3, putative | 0.0171 | 0.4229 | 0.4229 |
Onchocerca volvulus | 0.0347 | 0.9772 | 0.9772 | |
Echinococcus granulosus | casein kinase I alpha | 0.0355 | 1 | 1 |
Loa Loa (eye worm) | CK1/CK1/CK1-A protein kinase | 0.0355 | 1 | 1 |
Trichomonas vaginalis | CK1 family protein kinase | 0.0355 | 1 | 1 |
Brugia malayi | Protein kinase domain containing protein | 0.0283 | 0.7752 | 0.7752 |
Entamoeba histolytica | casein kinase, putative | 0.0355 | 1 | 1 |
Toxoplasma gondii | casein kinase I | 0.0355 | 1 | 1 |
Trypanosoma cruzi | casein kinase, putative | 0.0355 | 1 | 1 |
Schistosoma mansoni | protein kinase | 0.0355 | 1 | 1 |
Echinococcus multilocularis | glycogen synthase kinase 3 beta | 0.0171 | 0.4229 | 0.4229 |
Echinococcus granulosus | casein kinase I delta | 0.0355 | 1 | 1 |
Trichomonas vaginalis | CK1 family protein kinase | 0.0355 | 1 | 1 |
Echinococcus granulosus | casein kinase I gamma | 0.0283 | 0.7752 | 0.7752 |
Schistosoma mansoni | glycogen synthase kinase 3-related (gsk3) (cmgc group III) | 0.0171 | 0.4229 | 0.4229 |
Echinococcus granulosus | casein kinase I alpha | 0.0355 | 1 | 1 |
Brugia malayi | intracellular kinase | 0.0171 | 0.4229 | 0.4229 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0355 | 1 | 1 |
Plasmodium falciparum | casein kinase 1 | 0.0355 | 1 | 1 |
Echinococcus multilocularis | casein kinase i | 0.0355 | 1 | 1 |
Trypanosoma cruzi | casein kinase, putative | 0.0355 | 1 | 1 |
Echinococcus granulosus | glycogen synthase kinase 3 beta | 0.0171 | 0.4229 | 0.4229 |
Trichomonas vaginalis | CK1 family protein kinase | 0.0355 | 1 | 1 |
Loa Loa (eye worm) | protein kinase domain-containing protein | 0.0283 | 0.7752 | 0.7752 |
Echinococcus multilocularis | protein kinase shaggy | 0.0171 | 0.4229 | 0.4229 |
Leishmania major | casein kinase, putative | 0.0355 | 1 | 1 |
Echinococcus multilocularis | casein kinase I alpha | 0.0355 | 1 | 1 |
Onchocerca volvulus | 0.0286 | 0.785 | 0.785 | |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0171 | 0.4229 | 0.4229 |
Echinococcus granulosus | casein kinase I delta | 0.0355 | 1 | 1 |
Echinococcus granulosus | casein kinase I alpha | 0.0355 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 5.8584 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.